Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Proc Zool Soc ; 74(4): 432-442, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34866764

RESUMEN

Green vegetables, fruits, cereals, and pulses are all rich sources of antioxidants. Retinoic acid, ascorbate, proanthocyanidins, tannins, saponins, melatonin, curcumin, allicin, and alpha-lipoic acid stand documented in plants as bioactive compounds. The international dietary committee advocates a specific quantum of these natural antioxidants through diet. Interestingly, environmental pollution has indeed affected most of these farm products. The use of chemical fertilizers, pesticides and heavy metals in soil has a cumulative effect on human health. Enough evidence is available for the presence of phytoestrogen, xenoestrogen, and a host of other endocrine disruptors in the food. These plant-based nutrients can mimic or enhance the natural hormone's health effects. While endocrine disruptors are found in many everyday products, this review aims to address endocrine disruptors from food in the Asian subcontinent. 'Food for thought' justifies the paradigm shift towards good endocrine health by swaying away from the conventional daily dietary recommendations.

2.
Interdiscip Toxicol ; 10(1): 20-29, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30123032

RESUMEN

The present study was undertaken to assess the degree of oxidative stress and toxic effects induced by chromium on hepatic tissue in male Wistar rats exposed to a realistic dosage of Cr(VI) (20 mg/kg/b.w./day) through drinking water, based on the levels of these metals found in the environment, for a duration of 15, 30 and 60 days. The protective effect of melatonin (10 mg/kg) was also studied by simultaneous administration with the metal. Levels of enzymatic and non-enzymatic antioxidants as well as lipid peroxidation were assessed. There was a significant decrease in enzymatic as well as non-enzymatic antioxidants and an increase in the lipid peroxidation level, which were prevented and maintained at near-normal levels by the administration of melatonin in all treatment periods. Metal accumulation was maximal at 15 days, with gradual decreases till 60 days. Histopathological observations also demonstrated the fact that Cr (VI) exposure leads to cytological lesions in the hepatic tissue promoting cellular necrotic/apoptotic changes, while melatonin was able to counteract insults induced by Cr (VI) at all treatment periods. It also prevented alterations in insulin and glucose levels. Overall, the present study suggests a duration-dependent effect of Cr on hepatic oxidative stress and cytotoxicity and shows the potent activity of melatonin in preventing the negative effects of Cr (VI).

3.
Drug Chem Toxicol ; 35(2): 167-77, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22268556

RESUMEN

The present study was taken up to assess the role of subchronic exposure to an environmentally relevant dosage of cadmium in type l diabetes. Female rats of the Wistar strain were treated with cadmium (5.12 mg/kg body weight) for 45 days. On day 46, rats were made diabetic by alloxan. After 7 days, diabetes (i.e., animals with serum glucose greater than 300 mg/dL) in the alloxanized animals was confirmed and further experiments were conducted for 15 days. Cadmium pretreatment showed disturbed glucose homeostasis with attendant changes in carbohydrate metabolism, coupled with decrease in food and water intake. Disturbance in carbohydrate metabolism was indicated by altered tissue metabolite load, as marked by a decrease in protein and glycogen contents and increased cholesterol store. Poor glucose clearance subsequent to a glucose challenge under the glucose tolerance test was observed in these animals (0.48/min in control vs. 0.13/min in Cd animals). There was a significantly lower glucose elevation rate in the insulin response test subsequent to an insulin-induced decrease in glucose level in Cd-exposed animals. Elevated oxidative stress was marked by increased lipid peroxidation, decreased antioxidant (both nonenzymatic and enzymatic) levels, and serum markers of hepatic and renal damage. Decreased corticosterone levels, together with increased E2 and reduced P4 levels, were some of the hallmark changes in the serum hormone profile of Cd-exposed animals. Overall, the present results are novel and interesting to open more investigations on animal models of type 1 diabetes with a history of previous Cd exposure.


Asunto(s)
Glucemia/metabolismo , Cadmio/farmacología , Diabetes Mellitus Tipo 1/metabolismo , Riñón/metabolismo , Hígado/metabolismo , Fosfatasa Ácida/sangre , Fosfatasa Alcalina/sangre , Animales , Intoxicación por Cadmio/sangre , Intoxicación por Cadmio/metabolismo , Colesterol/sangre , Corticosterona/sangre , Ingestión de Líquidos/fisiología , Ingestión de Alimentos/fisiología , Estradiol/sangre , Femenino , Prueba de Tolerancia a la Glucosa , Insulina/análisis , Progesterona/sangre , Ratas , Ratas Wistar , Triglicéridos/sangre
4.
J Matern Fetal Neonatal Med ; 25(6): 831-44, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21848498

RESUMEN

OBJECTIVE: To evaluate the long-term plasticity changes induced by neonatal corticosterone programming on adult metabolic status and the deprogramming effect of melatonin. METHODS: Male and female Wistar rats were maintained under standard conditions and when mated females delivered pups, neonates of both sexes were separated and equal number of pups was assigned to lactating mothers. Pups treated with saline, corticosterone or a combination of corticosterone and melatonin from PND 2 to PND 14, were maintained until 120 days of age. Various serum and tissue parameters pertaining to glycaemic regulation, dyslipidemia, hepatic and renal distress and oxidative stress were analyzed in adult rats. RESULTS: Neonatal corticosterone exposure induced dyslipidemia, increased fed and fasting glucose levels, insulin resistance, lipid peroxidation, serum levels of insulin, corticosterone and hepatic and renal dysfunction markers and decreased the levels of enzymatic and non-enzymatic antioxidants, relatively more in males. Melatonin proved as an effective deprogrammer of corticosterone induced plasticity changes. CONCLUSIONS: Neonatal corticosterone exposure induces long lasting effects on adult physiology and metabolism. Concurrent treatment with melatonin effectively deprograms the changes.


Asunto(s)
Corticosterona/farmacología , Crecimiento y Desarrollo/efectos de los fármacos , Homeostasis/efectos de los fármacos , Melatonina/farmacología , Metabolismo/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Animales , Animales Recién Nacidos , Peso Corporal/efectos de los fármacos , Peso Corporal/fisiología , Ingestión de Líquidos/efectos de los fármacos , Ingestión de Líquidos/fisiología , Ingestión de Alimentos/efectos de los fármacos , Ingestión de Alimentos/fisiología , Femenino , Homeostasis/fisiología , Masculino , Metabolismo/fisiología , Estrés Oxidativo/fisiología , Embarazo , Ratas , Ratas Wistar
5.
Exp Toxicol Pathol ; 64(5): 441-8, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21106356

RESUMEN

Methanolic extracts of Pterocarpus marsupium Roxb (P. marsupium) and Ocimum sanctum Linn (O. sanctum) were prepared separately and then administered to both non-diabetic and alloxan induced diabetic adult female Wistar rats as a mixture of both at a dosage of 500mg/kg body weight, and its effect was checked on serum and tissue lipids together with corticosterone, estrogen and progesterone profile. Further, tissue load of metabolites (cholesterol), enzymatic and non-enzymatic antioxidant status together with lipid peroxidation levels and serum markers of hepatic and renal damage were also assessed. Results of the present study strongly support the possibility of this herbal combination in humans to meet the objective of achieving a holistic amelioration and cure of diabetes as, the herbal extract mixture of P. marsupium and O. sanctum has succeeded in not only rectifying dyslipidemia but also in restoring the endogenous antioxidant levels to the pre diabetic status. Herbal preparations are ideal candidates of choice and in this context, the present combination of P. marsupium and O. sanctum provides compelling evidence for a holistic efficacy in amelioration of associated diabetic manifestations/dysregulations.


Asunto(s)
Antioxidantes/farmacología , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Fitoterapia/métodos , Extractos Vegetales/farmacología , Animales , Modelos Animales de Enfermedad , Femenino , Ocimum/química , Estrés Oxidativo/efectos de los fármacos , Corteza de la Planta/química , Hojas de la Planta/química , Preparaciones de Plantas/farmacología , Pterocarpus/química , Ratas , Ratas Wistar
6.
J Matern Fetal Neonatal Med ; 25(9): 1574-85, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22185560

RESUMEN

OBJECTIVE: The present study assesses the thrifty phenotype response of neonatal corticosterone programming to a diabetogenic challenge in adult rats and the role of melatonin as a deprogrammer. METHODS: Neonates of both sexes, born of healthy male and female rats maintained under standard conditions of temperature and light, were separated and, equal number of pups was assigned to lactating mothers. Pups treated with either saline or corticosterone or, a combination of corticosterone and melatonin from postnatal day (PND) 2 to PND 14 and, at 120 days of age, six animals from each treatment group were rendered diabetic by alloxanization. Various serum and tissue parameters pertaining to glycaemic regulation, dyslipidemia, hepatic and renal distress and oxidative stress were analysed in adult rats of all groups. RESULTS: The results indicate compromised feed efficiency, hyperglycaemia, hypoinsulinemia, decreased glycogen content, elevated serum and tissue lipids and serum markers of hepatic and renal stress, together with increased lipid peroxidation, and decreased levels of non-enzymatic and enzymatic antioxidants in corticosterone programmed diabetic animals than in the non-programmed diabetic rats. However, treatment with melatonin simultaneously prevented to a significant extent the alterations in carbohydrate and lipid metabolism and oxidative stress. CONCLUSIONS: Melatonin is a potent deprogrammer of neonatal corticosterone programming effects and the adult thrifty phenotype alteration to a diabetogenic challenge.


Asunto(s)
Corticosterona/farmacología , Diabetes Mellitus/inducido químicamente , Crecimiento y Desarrollo/efectos de los fármacos , Melatonina/farmacología , Estrés Oxidativo/efectos de los fármacos , Edad de Inicio , Animales , Animales Recién Nacidos , Corticosterona/antagonistas & inhibidores , Diabetes Mellitus/epidemiología , Diabetes Mellitus/fisiopatología , Antagonismo de Drogas , Femenino , Masculino , Fenotipo , Embarazo , Ratas , Ratas Wistar
7.
Artículo en Inglés | MEDLINE | ID: mdl-22754925

RESUMEN

The present study evaluates the efficacy of ethanolic extract of Boerhaavia diffusa L (BD) administered orally at a dose of 500mg/kg body weight for a period of 30 days to alloxanized diabetic rats and its efficacy compared with the standard hypoglycaemic drug metformin. Diabetic animals showed glycemic dysregulation, altered ionic balance, increased levels of serum markers of kidney function, and reduced Na+-K+ ATPase activity and endogenous antioxidant status. Administration of BD not only maintained the ionic balance and renal Na+-K+ ATPase activity but also significantly minimized diabetic hyperglycaemia. The renal antioxidant status (GPx, Catalase, SOD and GSH) remained in the near normal range and LPO level lower than the non-diabetic level. These effects are comparable to the changes brought about by metformin treatment and even better. Over all, the present study provides evidence for BD to be a potent renoprotective and antihyperglycaemic agent in diabetic animals.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Hipoglucemiantes/farmacología , Riñón/efectos de los fármacos , Nyctaginaceae , Extractos Vegetales/farmacología , Sustancias Protectoras/farmacología , Aloxano , Animales , Glucemia/efectos de los fármacos , Etanol , Femenino , Insulina/metabolismo , Riñón/patología , Estrés Oxidativo/efectos de los fármacos , Hojas de la Planta , Ratas , Ratas Wistar , Equilibrio Hidroelectrolítico/efectos de los fármacos
8.
Cardiovasc Toxicol ; 11(1): 78-88, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21046280

RESUMEN

Present study evaluates cardioprotective role of melatonin (Mel), alpha lipoic acid (ALA), a combination of melatonin and alpha lipoic acid (Mel + ALA) against cadmium (Cd)-induced oxidative damage. Female albino rats were subjected to 15-day exposure to Cd (5.12 mg/kg bw) alone or treated with ML (10 mg/kg bw) + ALA (25 mg/kg bw) simultaneously. Plasma markers of cardiac damage, cardiac free radical generation, lipid peroxidation, endogenous antioxidant status, cadmium load, metallothionein induction, and histopathology were evaluated in various experimental groups. Combination of Mel + ALA significantly prevented leakage of marker enzymes of cardiac damage, changes in cardiac free radical generation, endogenous antioxidants, antioxidant status, structural alterations and augmented the degree of metallothionein (MT) induction. The results demonstrate that ML + ALA co-administration effectively protected against Cd-induced cardiac oxidative damage.


Asunto(s)
Antioxidantes/farmacología , Cloruro de Cadmio , Cardiopatías/prevención & control , Melatonina/farmacología , Miocardio/metabolismo , Estrés Oxidativo/efectos de los fármacos , Ácido Tióctico/farmacología , Animales , Ácido Ascórbico/metabolismo , Biomarcadores/metabolismo , Sinergismo Farmacológico , Quimioterapia Combinada , Enzimas/metabolismo , Femenino , Glutatión/metabolismo , Cardiopatías/inducido químicamente , Cardiopatías/metabolismo , Cardiopatías/patología , Peróxido de Hidrógeno/metabolismo , Radical Hidroxilo/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Malondialdehído/metabolismo , Metalotioneína/metabolismo , Miocardio/patología , Ratas , Vitamina E/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...